@human3pod Avatar @human3pod Human [--] with Brom and Sam

Human [--] with Brom and Sam posts on YouTube about sam, biotech, brain, human the most. They currently have [-----] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence finance stocks vc firms technology brands exchanges celebrities countries social networks

Social topic influence sam, biotech, brain, human, fund, bio, founders fund, thiel, carbon, health

Top assets mentioned COMPASS Pathways plc (CMPS) Atai Life Sciences B.V. (ATAI) Hims & Hers Health, Inc. (HIMS)

Top Social Posts

Top posts by engagements in the last [--] hours

"Investing in Psychedelic BioTech (August [----] webinar replay) [----] has been the start of a bull period for psychedelic medicine. Psychedelic Biotechs like GH Research Compass Pathways and Lykos Therapeutics are releasing impressive late stage clinical trial data Capital is following the data: Cybin just raised $500M and Johnson and Johnson's Ketamine-inspired antidepressant Spravato broke $1B+ / year of topline. A new administration seems surprisingly interested in accelerating the FDA approval of psychedelics as treatments for mental health disorders Learn how top VCs and LPs are mapping and"
YouTube Link 2025-07-30T22:31Z [----] followers, [---] engagements

"Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field Ryan Field is the CEO of Kernel a brain-computer interface company founded by Bryan Johnson. Kernel is a cutting edge non-invasive BCI that uses fNIRS to image the brain. Imagine if getting an MRI was as easy as putting on a bike helmet: that's Kernel in a nutshell. Kernel is developing several applications on top of their device including (A) predicting which antidepressant you will respond best to and (B) BrainAge a cognitive assesment that tells you how young your brain is relative to your chronological age. Ryan joins Brom"
YouTube Link 2025-07-22T11:00Z [----] followers, [---] engagements

"AI designed mRNA therapies: a Universal Toolkit for Genetic Medicine Google-backed founder explains Amit Deshwar is the Founder & CTO of Kerna Labs. Backed by Gradient Ventures (Google's AI fund) Kerna Labs is building foundational AI models that aim to unlock the full potential of mRNA as the universal toolkit for genetic medicine. Kerna Labs' CSO is Melissa J. Moore the former CSO of Moderna who helped lead the development of the Moderna COVID vaccine. Topics include: - What is RNA - What is an mRNA therapeutic - The potential of mRNA therapeutics vs traditional drugs - How AI fits into the"
YouTube Link 2025-01-28T12:15Z [----] followers, [---] engagements

"RFK says FDA approved legal psychedelic therapy is coming in the next year $CMPS $ATAI"
YouTube Link 2025-06-25T19:08Z [----] followers, [---] engagements

"Founder's Fund (Peter Thiel) and Lower Carbon Capital (Chris Sacca) both love biomanufacturing Despite having different ideologies"
YouTube Link 2025-07-01T17:00Z [----] followers, [---] engagements

"Elon Musks Neuralink raised $650M but there's much more in brain computer interface (BCI) startups"
YouTube Link 2025-06-23T21:58Z [----] followers, [---] engagements

"3: MindMed Deep Dive. JR Rahn LSD Nasdaq Uplisting Pump and Dump or To the Moon Many of us have already 10x'd our money on MindMedicine (MMED / MMEDF): should we take our profits now or hold for the next [--] years Brom dives deep into this topic and looks at questions like: Will the Nasdaq uplisting happen Is MindMed's drug development pipeline strong Why is MindMed associated with sketchy pump and dump groups like Departures Capital and Market Jar Media Do they have a way to capitalize on their research WTF is Kevin O'Leary doing in a drug company Why did JR Rahn sell his shares Does MindMed"
YouTube Link 2021-03-07T21:03Z [----] followers, [----] engagements

"Compass and ATAI latest news + are Psychedelics BACK in [----] The past few years have been rough for psychedelic and shroom stocks but recent news from ATAI (and Recognify) Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make me think that Psychedelics are back on the menu in [----]. In this video I discuss: 0:00 - why psychedelics are hot again in [----] 5:45 - latest thoughts on Compass a month after their Phase [--] topline data 9:45 - thoughts on ATAI / Recognify and how this feeds back into our psychedelic macro theme Join our investing in psychedelics webinar"
YouTube Link 2025-07-29T11:00Z [----] followers, [---] engagements

"How to start a VC fund I interviewed Michael Huseby to learn about his life story and his new book: Fundamentals: Your Friendly Guide to Investment Funds and Syndications This is a great listen for anyone interested in starting an investment fund or interested in making the transition from "practitioner" to "practitioner operator" like Michael did when leaving BigLaw to start his firm and like I did when leaving the hedge fund I was to start my own fund. We cover: 0:00 - Michael's backstory. Big Law. Going blind. The road to Entrepreneurship 16:30 - from legal practitioner to legal"
YouTube Link 2025-07-15T16:56Z [----] followers, [--] engagements

"As a venture capitalist some of the best pitches I see are structured this way. Works for LPs also"
YouTube Link 2025-06-06T15:14Z [----] followers, [---] engagements

"$HIMS Q2 Results - our take as healthcare venture capitalists Brom Rector and Sam Tabone from XEIA Venture Partners - a VC firm that invests in the future of human health wellbeing and performance - discuss $HIMS Q2 results and the HIMS business more broadly. We spend a lot of time discussing the legality of HIMS current FDA strategy and how/if HIMS can compete in a world with increasing competition from players like Function Health and Superpower. This is not financial advice. www.xeiavp.com hims $hims hims $hims"
YouTube Link 2025-08-05T11:00Z [----] followers, [---] engagements

"Analyzing the Compass Pathways Phase [--] Psilocybin trial ($CMPS) Brom Rector and Sam Tabone analyze Compass Pathways ($CMPS) Phase [--] Psilocybin trial interim readout in this podcast clip. Full episode here: https://youtu.be/oDmKHUj_MA8si=OtyVq0f5GHW11XdY CMPS psychedelics CMPS psychedelics"
YouTube Link 2025-06-25T17:10Z [----] followers, [---] engagements

"Using AI to uncover nature's hidden cures - Lars Wilde of Pangea Bio Lars Wilde is the cofounder of Pangea Bio - startup that uses AI to identify natural compounds and traditional remedies that may have medical applications. Prior to starting Pangea Lars cofounded Compass Pathways and ATAI life sciences both of which IPOd on the NASDAQ"
YouTube Link 2025-05-10T23:21Z [----] followers, [---] engagements

"Compass Pathways Phase [--] Psilocybin trial results - Psychedelic Stock down 50% Compass Pathways ($CMPS) released an interim readout from their Phase [--] trial of Psilocybin (COMP360) for treatment resistant depression (TRD). The data was positive and highly anticipated by the psychedelic community but the stock dropped 50% on June 23rd. Brom Rector and Sam Tabone of XEIA Venture Partners react and comment in this emergency podcast. We discuss: 0:00 - what did the Compass Pathways data readout actually say 12:00 - putting the Compass trial results into context vs SSRIs Lexapro Spravato and"
YouTube Link 2025-06-24T11:01Z [----] followers, [----] engagements

"Beyond Neuralink - Investing in Brain Computer Interfaces webinar replay Replay of our webinar on investing in brain computer interfaces. Join our upcoming July 30th event on investing in psychedelic biotech: www.psybio.org"
YouTube Link 2025-07-12T20:21Z [----] followers, [---] engagements

"The biggest myth about biotech investing It doesn't take [--] years and $1B to get a drug approved. Smart investors know this. #vc #venture capital #vc #venture capital"
YouTube Link 2025-06-05T15:17Z [----] followers, [---] engagements

"Brain implants without a hole in your skull - Wes Jones of Vonova Wes Jones is the CEO of Vonova a brain computer interface company that (unlike Neuralink) is enabling access to the brain without drilling a hole in your skull. Wes joins Brom Rector and Sam Tabone to discuss: 1:25 - how Wes got into neuro background as a catheter engineer 6:30 - how Wess parachute malfunction and resulting paralysis made him focused on the brain 10:30 - how Wes met his cofounder 14:00 - Wes demonstrating how his device treats chronic subdural hematoma 18:00 - ancient Peruvian history of brain surgery + the"
YouTube Link 2025-06-10T14:18Z [----] followers, [---] engagements

"The MAGA biotech agenda #podcast What do Trump and RFK care about when it comes to biotech"
YouTube Link 2025-07-04T00:00Z [----] followers, [---] engagements

"Trump and RFK's America First vision for bio What does MAGA want for bio and biomanufacturing They see it as a question of sovereignty. Arye Lipman and Biosphere discuss. Full episode here: https://youtu.be/Gals4C3gg18"
YouTube Link 2025-07-02T18:30Z [----] followers, [--] engagements

""American Dynamism" and "Save the planet" unite around this tech Both Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital invested in Biosphere (Arye Lipman's startup). Lower Carbon is focused on saving the planet from climate change while Founders Fund isn't sure climate change exists. How do these opposing viewpoints unite around biomanufacturing Full episode here: https://youtu.be/Gals4C3gg18"
YouTube Link 2025-06-30T18:45Z [----] followers, [--] engagements

"Many investors erroneously think that biotech only has binary outcomes - this is wrong"
YouTube Link 2025-06-07T18:04Z [----] followers, [---] engagements

"The BioPunk Revolution Elliot Roth is the founder of the BioPunk community lab. He believes that biotech is broken and that "BioPunks" can fix it. Elliot sits down with Brom Rector and Sam Tabone to discuss: 0:00 - what is BioPunk 6:15 - steel-manning the status quo 13:45 - how can institutions be more BioPunk 21:30 - is the BioPunk ethos even compatible with the VC model 26:20 - what will the world look like when the BioPunk movement succeeds 37:00 - how BioPunk can succeed where academia has failed 45:30 - how Elliot and the BioPunks want to change the system 1:01:00 - Elliots take on DeSci"
YouTube Link 2025-06-05T17:01Z [----] followers, [---] engagements

"Elliot Marseille - UC Berkeley Healthcare Economist on the Economic Viability of Psychedelic Therapy Will MDMA and psychedelic therapy be affordable There are lots of questions about the economic and financial future of psychedelic therapies. How much will they cost Will insurance cover them And more fundamentally how does one even begin to quantify the value of a psychedelic experience Todays guest Elliot Marseille PhD is here to explore all these questions and more. Dr. Marseille is a leading expert on the economics of the emerging psychedelic-assisted therapies. He is the founding Director"
YouTube Link 2023-08-06T10:47Z [----] followers, [---] engagements

"The BioIndustrial Revolution: Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup Arye Lipman is the cofounder of Biosphere a startup that recently raised millions of dollars from Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital to Unleash Industrial Biomanufacturing at scale. Biosphere is replacing the 1950's steam bioreactor with a modern UV-enabled design that reduces the capital intensity of biomanufacturing. Arye joins Brom Rector and Sam Tabone to share how biomanufacturing promises to unlock a new era of global abundance and American sovereignty. We"
YouTube Link 2025-06-30T11:00Z [----] followers, [---] engagements

"Stanford PostDoc is skeptical of AI in Drug Discovery Sam Banister PhD shares his thoughts on AI in drug discovery. Full episode here: https://youtu.be/N_xXPCOqnp4"
YouTube Link 2025-07-10T18:00Z [----] followers, [--] engagements

"What a resume"
YouTube Link 2025-05-30T16:04Z [----] followers, [--] engagements

"Investing in Human [--] - the new epoch of health wellbeing and performance Sam Tabone Partner at XEIA joins Brom on the podcast to discuss XEIA's "Human 3" thesis. Check out XEIA at https://www.xeiavp.com/ Timestamps 0:00 - why we created Human [--] - going from psychedelic medicine to the broader Human [--] space 8:00 - critiquing the Human [--] manifesto 12:00 - regulatory and social drivers of Human 19:00 - what Human [--] is NOT 31:00 - what defines Human [--] / what Human [--] is 50:00 - areas where Human [--] can make the biggest impact 58:00 - distribution shifting technologies 1:10:00 - how Human [--] is"
YouTube Link 2025-05-07T21:00Z [----] followers, [---] engagements

"Project Stargate AI agents is Trump transitioning us from the Anthropocene to the Synthocene Ramsay Brown founder of Mission Control - a leading provider of AI agents / synthetic workers to the defense industry joins us to discuss the end of the Anthropocene what a world filled with synthetic labor looks like Project Stargate Trump and AI why you need to be Rick Rubin and more. Learn more about Mission Control at https://usemissioncontrol.com/ Follow Rams on X: https://x.com/_ramsaybrown Follow Brom on X: https://x.com/therealbrom"
YouTube Link 2025-01-23T12:30Z [----] followers, [---] engagements

"Beyond Neuralink - investing in brain computer interfaces webinar A recording of our July 8th webinar. Learn more about our BCI investments on www.xeiavp.com"
YouTube Link 2025-07-12T19:10Z [----] followers, [--] engagements

"Designing Novel Brain Drugs with Xylo Bio Xylo is a biotech startup that is using computational methods and rigorous medicinal chemistry to design novel brain drugs to treat mental health and neurological disorders by rewiring neural circuits and restoring brain function. Many of their drug candidates are inspired by naturally occurring psychedelic drugs but are specifically designed to not induce hallucinations. Xylo's cofounders Josh Ismin and Sam Banister join Brom Rector and Sam Tabone to discuss: 3:25 - Xylo origins + why design novel psychedelic molecules 10:30 - How Xylos AI approach"
YouTube Link 2025-07-08T11:00Z [----] followers, [---] engagements

"Psychedelics and AI and in [----] with Dillan DiNardo of Y Combinator-backed Mindstate Design Labs Dillan DiNardo the founder and CEO of Mindstate Design Labs a drug development company using AI to enable the precision design of altered states of consciousness joins the podcast to discuss the state of psychedelics AI consciousness why Marc Andreessen hates psychedelics and the intersection of all these things. PS - my camera broke during the filming so we only have a view of Dillan Follow Brom on Twitter: https://twitter.com/therealbrom Learn more about Mindstate: https://www.mindstate.design/"
YouTube Link 2025-01-17T12:00Z [----] followers, [---] engagements

"Top [--] Human [--] startups - brain implants concierge longevity medicine designer psychedelics & more Brom Rector and Sam Tabone get specific on what Human [--] looks like in practice by analyzing [--] startups through the Human [--] lens. We analyze the companies on the [--] pillars of Human [--] - Distribution shifting potential - can this company elevate the already healthy in addition to healing the sick - HERO - is the company inspired by Historical Examples of Real-world Outcomes - Step Change potential - if this thing works will it be an order of magnitude better than the standard of care - Endogenous"
YouTube Link 2025-05-15T12:00Z [----] followers, [---] engagements

"Sometimes investors use your own words against you - happens both when pitching VCs and LPs"
YouTube Link 2025-06-06T19:10Z [----] followers, [---] engagements

"Can electricity cure brain cancer Ben Woodington of Coherence Neuro on BCIs in oncology Ben Woodington is the cofounder and CEO of Coherence Neuro. Coherence's is building the SOMA-1 a brain computer interface (BCI) that is designed to treat Glioblastoma (a type of brain cancer). Coherence's cancer focus sets them apart from other BCI companies like Neuralink and Synchron. Ben joins Brom Rector on the podcast to discuss: 0:00 - Intro 1:38 - What does BCI (brain-computer interface) actually mean 3:55 - The deadly brain cancer that Coherence is treating 8:01 - How can you treat cancer with"
YouTube Link 2025-05-27T11:30Z [----] followers, [--] engagements

"The genetic revolution in treating neurodegenerative disease Martin Jacko is the founder of Aperture Therapeutics a startup developing ASO (Antisense Oligonucleotide) based therapies for neurodegenerative diseases like ALS. Aperture's approach is unique in how they are guided by genetic profiles of individuals who are naturally resilient to neurodegenerative diseases. Martin joins Sam Tabone and Brom Rector to discuss 5:00 - Aperture origin story 10:00 - history of trying to cure ALS why [---] attempts failed 25:00 - why neuro is hot right now - genetic medicine 33:00 - why [--] and me failed"
YouTube Link 2025-06-17T13:39Z [----] followers, [---] engagements

"SEAL Team [--] Veteran & TARA Mind Founder Marcus Capone on Psychedelic Therapy: from SEALS to Startups Marcus Capone is founder of TARA Mind. TARA Mind is an employee benefit provider that allows companies of all sizes to offer Ketamine therapy to their employees as a mental health benefit. Marcus is also the Chairman and Co-Founder of VETS: Veterans Exploring Treatment Solutions VETS is a non profit that provides resources research and advocacy for U.S. Special Operations veterans seeking alternative mental health treatments. Marcus is a Veteran Navy SEAL Marcus retired from active duty in"
YouTube Link 2025-03-20T11:01Z [----] followers, [--] engagements

"How Xylo is developing psychedelics without the trip Xylo Bio is developing drugs that have the same therapeutic benefit as psychedelics but without the hallucinations or trip. Full episode here: https://youtu.be/N_xXPCOqnp4"
YouTube Link 2025-07-09T18:00Z [----] followers, [--] engagements

"Can electricity cure brain cancer Ben Woodington of Coherence Neuro on BCIs in oncology Ben Woodington is the cofounder and CEO of Coherence Neuro. Coherence's is building the SOMA-1 a brain computer interface (BCI) that is designed to treat Glioblastoma (a type of brain cancer). Coherence's cancer focus sets them apart from other BCI companies like Neuralink and Synchron. Ben joins Brom Rector on the podcast to discuss: 0:00 - Intro 1:38 - What does BCI (brain-computer interface) actually mean 3:55 - The deadly brain cancer that Coherence is treating 8:01 - How can you treat cancer with"
YouTube Link 2025-05-27T13:40Z [----] followers, [---] engagements

"OpenAI and SpaceX are even worse than most biotechs"
YouTube Link 2025-06-08T18:58Z [----] followers, [---] engagements

"Bryan Johnsons Neuralink competitor"
YouTube Link 2025-07-22T17:35Z [----] followers, [---] engagements

"Why we're excited about investing in mental health"
YouTube Link 2025-06-06T02:23Z [----] followers, [---] engagements

"Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup #podcastclips Arye Lipman is the cofounder of Biosphere a startup that recently raised millions of dollars from Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital to Unleash Industrial Biomanufacturing at scale. Biosphere is replacing the 1950's steam bioreactor with a modern UV-enabled design that reduces the capital intensity of biomanufacturing"
YouTube Link 2025-06-30T16:01Z [----] followers, [---] engagements

"Epigenetic Medicine with Laura Hsieh of TippingPoint Biosciences Laura Hsieh is the founder of TippingPoint Biosciences an epigenetic medicine startup that has developed a breakthrough method of drugging the entire chromatin network to create first-in-class epigenetic therapeutics. Laura sits down with Sam Tabone and Brom Rector to discuss: 1:11 Lauras background and the history of TippingPoint 5:30 What is Epigenetics and what is Chromatin 10:30 What diseases are driven by Epigenetics and dysfunctional Chromatin 14:00 - TippingPoints platform and secret sauce 19:10 - How TippingPoint runs"
YouTube Link 2025-05-22T11:01Z [----] followers, [---] engagements

"Is being a "value-add" investor an anti-signal What does being a "value-add" investor even mean"
YouTube Link 2025-06-04T15:11Z [----] followers, [----] engagements

"The government's top [--] Tech Priorities #ai #quantum and #biotech What technologies does the Trump administration care about"
YouTube Link 2025-07-03T00:45Z [----] followers, [---] engagements

"Glioblastoma is a devastating disease Which is why Coherence Neuro is fighting it #startups #vc"
YouTube Link 2025-05-29T16:27Z [----] followers, [---] engagements

"Falling for the deeptech fallacy could kill your #startup #vc"
YouTube Link 2025-06-18T15:01Z [----] followers, [---] engagements

"$HIMS Q2 Results - our take as healthcare venture capitalists Brom Rector and Sam Tabone from XEIA Venture Partners - a VC firm that invests in the future of human health wellbeing and performance - discuss $HIMS Q2 results and the HIMS business more broadly. We spend a lot of time discussing the legality of HIMS current FDA strategy and how/if HIMS can compete in a world with increasing competition from players like Function Health and Superpower. This is not financial advice. www.xeiavp.com hims $hims hims $hims"
YouTube Link 2025-08-05T11:00Z [----] followers, [---] engagements

"Investing in Psychedelic BioTech (August [----] webinar replay) [----] has been the start of a bull period for psychedelic medicine. Psychedelic Biotechs like GH Research Compass Pathways and Lykos Therapeutics are releasing impressive late stage clinical trial data Capital is following the data: Cybin just raised $500M and Johnson and Johnson's Ketamine-inspired antidepressant Spravato broke $1B+ / year of topline. A new administration seems surprisingly interested in accelerating the FDA approval of psychedelics as treatments for mental health disorders Learn how top VCs and LPs are mapping and"
YouTube Link 2025-07-30T22:31Z [----] followers, [---] engagements

"Compass and ATAI latest news + are Psychedelics BACK in [----] The past few years have been rough for psychedelic and shroom stocks but recent news from ATAI (and Recognify) Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make me think that Psychedelics are back on the menu in [----]. In this video I discuss: 0:00 - why psychedelics are hot again in [----] 5:45 - latest thoughts on Compass a month after their Phase [--] topline data 9:45 - thoughts on ATAI / Recognify and how this feeds back into our psychedelic macro theme Join our investing in psychedelics webinar"
YouTube Link 2025-07-29T11:00Z [----] followers, [---] engagements

"Bryan Johnsons Neuralink competitor"
YouTube Link 2025-07-22T17:35Z [----] followers, [---] engagements

"Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field Ryan Field is the CEO of Kernel a brain-computer interface company founded by Bryan Johnson. Kernel is a cutting edge non-invasive BCI that uses fNIRS to image the brain. Imagine if getting an MRI was as easy as putting on a bike helmet: that's Kernel in a nutshell. Kernel is developing several applications on top of their device including (A) predicting which antidepressant you will respond best to and (B) BrainAge a cognitive assesment that tells you how young your brain is relative to your chronological age. Ryan joins Brom"
YouTube Link 2025-07-22T11:00Z [----] followers, [---] engagements

"How to start a VC fund I interviewed Michael Huseby to learn about his life story and his new book: Fundamentals: Your Friendly Guide to Investment Funds and Syndications This is a great listen for anyone interested in starting an investment fund or interested in making the transition from "practitioner" to "practitioner operator" like Michael did when leaving BigLaw to start his firm and like I did when leaving the hedge fund I was to start my own fund. We cover: 0:00 - Michael's backstory. Big Law. Going blind. The road to Entrepreneurship 16:30 - from legal practitioner to legal"
YouTube Link 2025-07-15T16:56Z [----] followers, [--] engagements

"Beyond Neuralink - Investing in Brain Computer Interfaces webinar replay Replay of our webinar on investing in brain computer interfaces. Join our upcoming July 30th event on investing in psychedelic biotech: www.psybio.org"
YouTube Link 2025-07-12T20:21Z [----] followers, [---] engagements

"Stanford PostDoc is skeptical of AI in Drug Discovery Sam Banister PhD shares his thoughts on AI in drug discovery. Full episode here: https://youtu.be/N_xXPCOqnp4"
YouTube Link 2025-07-10T18:00Z [----] followers, [--] engagements

"How Xylo is developing psychedelics without the trip Xylo Bio is developing drugs that have the same therapeutic benefit as psychedelics but without the hallucinations or trip. Full episode here: https://youtu.be/N_xXPCOqnp4"
YouTube Link 2025-07-09T18:00Z [----] followers, [--] engagements

"Designing Novel Brain Drugs with Xylo Bio Xylo is a biotech startup that is using computational methods and rigorous medicinal chemistry to design novel brain drugs to treat mental health and neurological disorders by rewiring neural circuits and restoring brain function. Many of their drug candidates are inspired by naturally occurring psychedelic drugs but are specifically designed to not induce hallucinations. Xylo's cofounders Josh Ismin and Sam Banister join Brom Rector and Sam Tabone to discuss: 3:25 - Xylo origins + why design novel psychedelic molecules 10:30 - How Xylos AI approach"
YouTube Link 2025-07-08T11:00Z [----] followers, [---] engagements

"The MAGA biotech agenda #podcast What do Trump and RFK care about when it comes to biotech"
YouTube Link 2025-07-04T00:00Z [----] followers, [---] engagements

"The government's top [--] Tech Priorities #ai #quantum and #biotech What technologies does the Trump administration care about"
YouTube Link 2025-07-03T00:45Z [----] followers, [---] engagements

"Trump and RFK's America First vision for bio What does MAGA want for bio and biomanufacturing They see it as a question of sovereignty. Arye Lipman and Biosphere discuss. Full episode here: https://youtu.be/Gals4C3gg18"
YouTube Link 2025-07-02T18:30Z [----] followers, [--] engagements

"Founder's Fund (Peter Thiel) and Lower Carbon Capital (Chris Sacca) both love biomanufacturing Despite having different ideologies"
YouTube Link 2025-07-01T17:00Z [----] followers, [---] engagements

""American Dynamism" and "Save the planet" unite around this tech Both Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital invested in Biosphere (Arye Lipman's startup). Lower Carbon is focused on saving the planet from climate change while Founders Fund isn't sure climate change exists. How do these opposing viewpoints unite around biomanufacturing Full episode here: https://youtu.be/Gals4C3gg18"
YouTube Link 2025-06-30T18:45Z [----] followers, [--] engagements

"Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup #podcastclips Arye Lipman is the cofounder of Biosphere a startup that recently raised millions of dollars from Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital to Unleash Industrial Biomanufacturing at scale. Biosphere is replacing the 1950's steam bioreactor with a modern UV-enabled design that reduces the capital intensity of biomanufacturing"
YouTube Link 2025-06-30T16:01Z [----] followers, [---] engagements

"The BioIndustrial Revolution: Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup Arye Lipman is the cofounder of Biosphere a startup that recently raised millions of dollars from Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital to Unleash Industrial Biomanufacturing at scale. Biosphere is replacing the 1950's steam bioreactor with a modern UV-enabled design that reduces the capital intensity of biomanufacturing. Arye joins Brom Rector and Sam Tabone to share how biomanufacturing promises to unlock a new era of global abundance and American sovereignty. We"
YouTube Link 2025-06-30T11:00Z [----] followers, [---] engagements

"RFK says FDA approved legal psychedelic therapy is coming in the next year $CMPS $ATAI"
YouTube Link 2025-06-25T19:08Z [----] followers, [---] engagements

"Analyzing the Compass Pathways Phase [--] Psilocybin trial ($CMPS) Brom Rector and Sam Tabone analyze Compass Pathways ($CMPS) Phase [--] Psilocybin trial interim readout in this podcast clip. Full episode here: https://youtu.be/oDmKHUj_MA8si=OtyVq0f5GHW11XdY CMPS psychedelics CMPS psychedelics"
YouTube Link 2025-06-25T17:10Z [----] followers, [---] engagements

"Compass Pathways Phase [--] Psilocybin trial results - Psychedelic Stock down 50% Compass Pathways ($CMPS) released an interim readout from their Phase [--] trial of Psilocybin (COMP360) for treatment resistant depression (TRD). The data was positive and highly anticipated by the psychedelic community but the stock dropped 50% on June 23rd. Brom Rector and Sam Tabone of XEIA Venture Partners react and comment in this emergency podcast. We discuss: 0:00 - what did the Compass Pathways data readout actually say 12:00 - putting the Compass trial results into context vs SSRIs Lexapro Spravato and"
YouTube Link 2025-06-24T11:01Z [----] followers, [----] engagements

"Elon Musks Neuralink raised $650M but there's much more in brain computer interface (BCI) startups"
YouTube Link 2025-06-23T21:58Z [----] followers, [---] engagements

"Falling for the deeptech fallacy could kill your #startup #vc"
YouTube Link 2025-06-18T15:01Z [----] followers, [---] engagements

"The genetic revolution in treating neurodegenerative disease Martin Jacko is the founder of Aperture Therapeutics a startup developing ASO (Antisense Oligonucleotide) based therapies for neurodegenerative diseases like ALS. Aperture's approach is unique in how they are guided by genetic profiles of individuals who are naturally resilient to neurodegenerative diseases. Martin joins Sam Tabone and Brom Rector to discuss 5:00 - Aperture origin story 10:00 - history of trying to cure ALS why [---] attempts failed 25:00 - why neuro is hot right now - genetic medicine 33:00 - why [--] and me failed"
YouTube Link 2025-06-17T13:39Z [----] followers, [---] engagements

"Brain implants without a hole in your skull - Wes Jones of Vonova Wes Jones is the CEO of Vonova a brain computer interface company that (unlike Neuralink) is enabling access to the brain without drilling a hole in your skull. Wes joins Brom Rector and Sam Tabone to discuss: 1:25 - how Wes got into neuro background as a catheter engineer 6:30 - how Wess parachute malfunction and resulting paralysis made him focused on the brain 10:30 - how Wes met his cofounder 14:00 - Wes demonstrating how his device treats chronic subdural hematoma 18:00 - ancient Peruvian history of brain surgery + the"
YouTube Link 2025-06-10T14:18Z [----] followers, [---] engagements

"OpenAI and SpaceX are even worse than most biotechs"
YouTube Link 2025-06-08T18:58Z [----] followers, [---] engagements

"Many investors erroneously think that biotech only has binary outcomes - this is wrong"
YouTube Link 2025-06-07T18:04Z [----] followers, [---] engagements

"Sometimes investors use your own words against you - happens both when pitching VCs and LPs"
YouTube Link 2025-06-06T19:10Z [----] followers, [---] engagements

"As a venture capitalist some of the best pitches I see are structured this way. Works for LPs also"
YouTube Link 2025-06-06T15:14Z [----] followers, [---] engagements

"Why we're excited about investing in mental health"
YouTube Link 2025-06-06T02:23Z [----] followers, [---] engagements

"The BioPunk Revolution Elliot Roth is the founder of the BioPunk community lab. He believes that biotech is broken and that "BioPunks" can fix it. Elliot sits down with Brom Rector and Sam Tabone to discuss: 0:00 - what is BioPunk 6:15 - steel-manning the status quo 13:45 - how can institutions be more BioPunk 21:30 - is the BioPunk ethos even compatible with the VC model 26:20 - what will the world look like when the BioPunk movement succeeds 37:00 - how BioPunk can succeed where academia has failed 45:30 - how Elliot and the BioPunks want to change the system 1:01:00 - Elliots take on DeSci"
YouTube Link 2025-06-05T17:01Z [----] followers, [---] engagements

"The biggest myth about biotech investing It doesn't take [--] years and $1B to get a drug approved. Smart investors know this. #vc #venture capital #vc #venture capital"
YouTube Link 2025-06-05T15:17Z [----] followers, [---] engagements

"Is being a "value-add" investor an anti-signal What does being a "value-add" investor even mean"
YouTube Link 2025-06-04T15:11Z [----] followers, [----] engagements

"What a resume"
YouTube Link 2025-05-30T16:04Z [----] followers, [--] engagements

"Glioblastoma is a devastating disease Which is why Coherence Neuro is fighting it #startups #vc"
YouTube Link 2025-05-29T16:27Z [----] followers, [---] engagements

"Can electricity cure brain cancer Ben Woodington of Coherence Neuro on BCIs in oncology Ben Woodington is the cofounder and CEO of Coherence Neuro. Coherence's is building the SOMA-1 a brain computer interface (BCI) that is designed to treat Glioblastoma (a type of brain cancer). Coherence's cancer focus sets them apart from other BCI companies like Neuralink and Synchron. Ben joins Brom Rector on the podcast to discuss: 0:00 - Intro 1:38 - What does BCI (brain-computer interface) actually mean 3:55 - The deadly brain cancer that Coherence is treating 8:01 - How can you treat cancer with"
YouTube Link 2025-05-27T13:40Z [----] followers, [---] engagements

"Epigenetic Medicine with Laura Hsieh of TippingPoint Biosciences Laura Hsieh is the founder of TippingPoint Biosciences an epigenetic medicine startup that has developed a breakthrough method of drugging the entire chromatin network to create first-in-class epigenetic therapeutics. Laura sits down with Sam Tabone and Brom Rector to discuss: 1:11 Lauras background and the history of TippingPoint 5:30 What is Epigenetics and what is Chromatin 10:30 What diseases are driven by Epigenetics and dysfunctional Chromatin 14:00 - TippingPoints platform and secret sauce 19:10 - How TippingPoint runs"
YouTube Link 2025-05-22T11:01Z [----] followers, [---] engagements

"Top [--] Human [--] startups - brain implants concierge longevity medicine designer psychedelics & more Brom Rector and Sam Tabone get specific on what Human [--] looks like in practice by analyzing [--] startups through the Human [--] lens. We analyze the companies on the [--] pillars of Human [--] - Distribution shifting potential - can this company elevate the already healthy in addition to healing the sick - HERO - is the company inspired by Historical Examples of Real-world Outcomes - Step Change potential - if this thing works will it be an order of magnitude better than the standard of care - Endogenous"
YouTube Link 2025-05-15T12:00Z [----] followers, [---] engagements

"Using AI to uncover nature's hidden cures - Lars Wilde of Pangea Bio Lars Wilde is the cofounder of Pangea Bio - startup that uses AI to identify natural compounds and traditional remedies that may have medical applications. Prior to starting Pangea Lars cofounded Compass Pathways and ATAI life sciences both of which IPOd on the NASDAQ"
YouTube Link 2025-05-10T23:21Z [----] followers, [---] engagements

"Investing in Human [--] - the new epoch of health wellbeing and performance Sam Tabone Partner at XEIA joins Brom on the podcast to discuss XEIA's "Human 3" thesis. Check out XEIA at https://www.xeiavp.com/ Timestamps 0:00 - why we created Human [--] - going from psychedelic medicine to the broader Human [--] space 8:00 - critiquing the Human [--] manifesto 12:00 - regulatory and social drivers of Human 19:00 - what Human [--] is NOT 31:00 - what defines Human [--] / what Human [--] is 50:00 - areas where Human [--] can make the biggest impact 58:00 - distribution shifting technologies 1:10:00 - how Human [--] is"
YouTube Link 2025-05-07T21:00Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing